Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Upper limb arterial disease is a rare condition compared to lower limb arterial disease. In the lower limb, chronic limb ischemia (CLI) is characterized by an intractable pain or an ulceration present for at least 2 weeks. Guidelines recommend to use Transcutaneous Oxygen pressure (TcPO2) measurement when a CLI is suspected to establish diagnostic with a threshold of 30 mmHg when ankle and toe systolic pressure are not available.
In the upper limb, there is no guideline to define CLI. When there is a wound preventing finger pressure measurement, TcPO2 is theoretically indicated. However, there is neither standardized site to measure nor threshold value of TcPO2.
The investigators hypothesized that normal TcPO2 may be different in the upper limb and that threshold value for CLI may also be different compared to lower limb.
The investigators planned a study with two parts:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Healthy Volunteers | TcPO2 measurement in the upper limb of healthy volunteers |
| |
| Patients with arterial disease in the upper limb and wound | Patients with arterial disease in the upper limb and wound (retrospective setting, research on data) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| TcPO2 measurement on the upper limb | Diagnostic Test | Measurement of the transcutaneous Oxygen Pressure in the upper limb of 30 healthy volunteers and of at least 30 patients. |
|
| Measure | Description | Time Frame |
|---|---|---|
| TcPO2 of the upper limb (blood pressure, measured in millimeters of mercury (mmHg)). | Measured on both healthy volunteers (4 sites of measure) and patients with arterial disease The measurements are carried out by non-invasive extracorporeal electrodes with CE (Conformité Européenne) marked equipment and used in accordance with the CE mark. | Healthy volunteers: Enrollment. Patients: 1 month after information letter sending. |
| Measure | Description | Time Frame |
|---|---|---|
| TcPO2 of the upper limb (mmHg) (only for the healthy volunteers) | average values of all TcPO2 values. | Enrollment |
| ROC (Receiving Operator Characteristic) curve for critical ischemia (only for the retrospective patients) |
Not provided
Healthy volunteers part:
Inclusion Criteria:
Exclusion Criteria:
Retrospective patients part:
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
The study population will be made of :
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Judith CATELLA, MD | Service de Médecine Interne - UF Explorations Fonctionnelles Vasculaires, HEH, HCL | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Service de Médecine Interne - UF Explorations Fonctionnelles Vasculaires, Hôpital Edouard Herriot | Lyon | Lyon | 69003 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D058729 | Peripheral Arterial Disease |
| ID | Term |
|---|---|
| D050197 | Atherosclerosis |
| D001161 | Arteriosclerosis |
| D001157 | Arterial Occlusive Diseases |
| D014652 | Vascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
critical ischemia is defined as an amputation more proximal than distal than the electrode or revascularization.
| 3 months |
| Sensitivity and specificity for critical ischemia (only for the retrospective patients) | critical ischemia is defined as an amputation more proximal than distal than the electrode or revascularization. Tested threshold: 30mmHg, 30 mmHg, 40mmHg, 50mmHg and 60mmHg | 3 months |
| patients characteristics (only for the retrospective patients) | age, sex, vascular risk factors, etiology, medical treatment, other treatments). | 3 months |
| healing (only for the retrospective patients) | number and percentage of healing without amputation and without revascularization | 3 months |
| level of amputation (only for the retrospective patients) | number and percentage of patients with an amputation level more proximal that the electrodes | 3 months |
| revascularization (only for the retrospective patient) | number and percentage of revascularization procedures | 3 months |
| healing after revascularization | percentage of healing following revascularization (only for the retrospective patient if data are available) | 3 months after revascularization |
| D002318 |
| Cardiovascular Diseases |
| D016491 | Peripheral Vascular Diseases |